Phaseline

Targets › HTR2C

HTR2C (5-hydroxytryptamine receptor 2C): drug programs, companies and trials

32 programs from 32 companies in 116 trials: 49 Phase 2, 29 Phase 4, 20 Phase 1, 18 Phase 3; Psychiatry, Other, Neurology; next expected readout Nov 2026.

G protein-coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various drugs and psychoactive substances, including ergot alkaloid derivatives, 1-2,5,-dimethoxy-4-iodophenyl-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). (UniProt, P28335)

Open in Phaseline: the race on HTR2C, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Brigham and Women's HospitalMIB 626 (NMN)
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC5A2, SLC6A2, GLP1R, UNKNOWN, Tubulin, OPRM1, NR3C2, AGTR1, IL4R, SLC6A4, HTR2A, HTR2CPhase 4Prostate Cancer; Stable Coronary Disease; Allergic Contact Dermatitis; Hypertension …Nov 2026
University of Pennsylvania2-[18F]-FA
Voltage-gated calcium channel modulator
CHRNA4, OPRK1, OPRD1, OPRM1, UL51, ADRA2A, ADRA2C, ADRA2B, Ion channels, CACNB4, CACNB2, CACNB1, CACNB3, TNF, SLC6A4, HTR2A, HTR2C, FKBP1A, CD86, CD80, PDE4A, PDE4D, PDE4B, PDE4C, PDE3A, CHRNB2, STNPhase 4Alcohol Use Disorder; Acute Kidney Injury; Insomnia; Giant Cell Arteritis …Nov 2026
John D. Dingell VA Medical CenterTrazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 4Sleep ApneaDec 2026
Tongji Universitytrazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 4Depressed Insomniac Co-morbid PatientsDec 2026
The University of Texas Health Science Center at San AntonioQuetiapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 4Parkinson's Disease PsychosisFeb 2027
Beth Israel Deaconess Medical CenterLorcaserin
Serotonin 2c (5-HT2c) receptor agonist
HTR2CPhase 4ObesityJun 2027
The Chaim Sheba Medical Centerrisperidone
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 4Velocardiofacial SyndromeAug 2027
Centre for Addiction and Mental HealthRisperidone
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 4Schizophrenia and Related DisordersSep 2027
Northwell Healthrisperidone
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 4Psychosis; Acute; Schizophenia DisorderDec 2029
Massachusetts General HospitalQuetiapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 4Bipolar I DisorderFeb 2030
VA Office of Research and DevelopmentTrazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 4Sleep Disordered BreathingJun 2030
Madigan Army Medical CenterCyclobenzaprine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
HTR2A, HTR2CPhase 4Low Back Pain–
Chinese University of Hong KongTrazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 4Mild Cognitive Impairment–
ZogenixFenfluramine
Serotonin 1d (5-HT1d) receptor agonist; Serotonin 2c (5-HT2c) receptor agonist; Sigma opioid receptor antagonist
HTR1D, HTR2C, SIGMAR1Phase 3CDKL5 Deficiency Disorder; Dravet Syndrome (DS); Dravet Syndrome; Infantile SpasmNov 2027
Foundation for Advancing Veterans' Health ResearchQuetiapine Fumarate
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 3Mild Traumatic Brain InjuryJun 2028
UCB BIOSCIENCESfenfluramine hydrochloride
Serotonin 1d (5-HT1d) receptor agonist; Serotonin 2c (5-HT2c) receptor agonist; Sigma opioid receptor antagonist
HTR1D, HTR2C, SIGMAR1Phase 3Rett SyndromeFeb 2029
University of MinnesotaQsymia
Phentermine/topiramate extended-release combination; sympathomimetic amine and carbonic an
ADRA1A, HTR2CPhase 3Healthy VolunteersOct 2030
University of North Carolina, Chapel HillCyclobenzaprine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
HTR2A, HTR2CPhase 2Acute Stress ReactionNov 2026
Washington State UniversityMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Stimulant Use DisorderDec 2026
University of MichiganCyclobenzaprine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
HTR2A, HTR2CPhase 2High Tone Pelvic Floor DysfunctionDec 2026
University of Triestemirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2RETT Syndrome With Proven MECP2 MutationDec 2026
Boryung PharmaceuticalOlanzapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; D2-like dopamine receptor antagonist
HTR2A, HTR2C, DRD2, DRD3, DRD4Phase 2Schizophrenia; Schizophrenia and Related Disorders; Chemotherapy Induced Nausea and Vomiting; Oncology Patients Receiving Chemotherapy …May 2027
Centre hospitalier de l'Université de Montréal (CHUM)Trazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 2Insomnia ChronicJul 2027
M.D. Anderson Cancer CenterMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Advanced CancerDec 2027
Tonix PharmaceuticalsCyclobenzaprine Hydrochloride (TNX-102)
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
HTR2A, HTR2CPhase 2Major Depressive Episode (MDE); PharmakokineticFeb 2028
Lone BaandrupQuetiapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 2Psychiatric DisordersFeb 2029
Centre Hospitalier St AnneTrazodone
Serotonin transporter inhibitor; Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist
SLC6A4, HTR2A, HTR2CPhase 2Depression - Major Depressive DisorderDec 2029
University of California, IrvineMirtazapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Adrenergic receptor alpha-2 antagonist
HTR2A, HTR2C, ADRA2A, ADRA2C, ADRA2BPhase 2Glioma of BrainDec 2030
University of California, San DiegoPhentermine-Topiramate
Sympathomimetic amine and gamma-aminobutyric acid modulator for weight loss
HTR2C, GABAPhase 2Colitis, Ulcerative–
Md. Moktadirul Hoque ShuvoTrifluoperazine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; D2-like dopamine receptor antagonist
HTR2A, HTR2C, DRD2, DRD3, DRD4Phase 2Functional Dyspepsia–
University of ArizonaZiprasidone
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 1SchizophreniaFeb 2027
Verinder SharmaQuetiapine
Serotonin 2a (5-HT2a) receptor antagonist; Serotonin 2c (5-HT2c) receptor antagonist; Dopamine D2 receptor antagonist
HTR2A, HTR2C, DRD2Phase 1Postpartum Depression–

Conditions

Obstructive Sleep Apnea (4) Schizophrenia (3) Multiple Myeloma (3) Advanced Cancer (2) Schizophrenia and Related Disorders (2) Advanced Malignant Solid Neoplasm (2) Prostate Cancer (2) Multiple Sclerosis (2) Cardiac Amyloidosis (2) Ulcerative Colitis (2) Alcohol Use Disorder (AUD) (2) Pediatric HIV Infection (2)

Modalities

small molecule (30), protein or peptide (1)

Companies

UCB BIOSCIENCES (1) M.D. Anderson Cancer Center (1) The Chaim Sheba Medical Center (1) Verinder Sharma (1) Washington State University (1) Boryung Pharmaceutical (1) University of Arizona (1) Northwell Health (1) University of North Carolina, Chapel Hill (1) University of California, Irvine (1) Brigham and Women's Hospital (1) Foundation for Advancing Veterans' Health Research (1) Md. Moktadirul Hoque Shuvo (1) University of Michigan (1) Centre hospitalier de l'Université de Montréal (CHUM) (1) University of Minnesota (1) John D. Dingell VA Medical Center (1) Zogenix (1) Madigan Army Medical Center (1) University of Pennsylvania (1)

Related targets

HTR2A (27) DRD2 (11) SLC6A4 (8) ADRA2A (5) ADRA2C (5) ADRA2B (5) HTR1D (2) SIGMAR1 (2) DRD3 (2) DRD4 (2) OPRM1 (2) SLC5A2 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.